Attributing Cause of Death for Patients with Clostridium diffi cile Infection
To the Editor: Hota et al. report that for deceased patients who had Clostridium diffi cile infection (CDI), agreement is poor between causes of death reported on death certifi cates and those categorized by a review panel (1) . Our data support the diffi culty of attributing cause of death for patients with CDI.
In 2004 in Quebec, Canada, a mandatory CDI surveillance program was implemented. Deaths that occurred within 30 days after CDI diagnosis were classifi ed as 1) directly attributable to CDI (e.g., toxic megacolon, septic shock), 2) having a CDI contribution (e.g., acute decompensation of chronic heart failure), or 3) unrelated to CDI (e.g., terminal cancer) (2) . To determine accuracy of the surveillance classifi cations, we compared cause-ofdeath classifi cation of 22 deceased CDI patients reported to surveillance by 1 hospital in 2007 with causes of death reported by 13 external reviewers who examined summaries of medical fi les of the deceased patients. Reviewers Variation among reviewers suggested that categorizations reported to surveillance were inaccurate. Number of deaths among patients with CDI, regardless of the cause of death, seemed to better indicate CDI severity. Since 2008, only the crude numbers of deaths, not subjected to individual interpretation, have been reported to surveillance. A questionnaire addressing concurrent medical conditions, prognosis, level of care, and circumstances of death is being implemented in Quebec hospitals participating in CDI surveillance and should help determine the role of CDI in deaths. All material published in Emerging Infectious Diseases is in the public domain and may be used and reprinted without special permission; proper citation, however, is required.
Characterization of Mycobacterium orygis
To the Editor: In a recently published study, van Ingen et al. (1) described the molecular characterization and phylogenetic position of the oryx bacillus, a member of the Mycobacterium tuberculosis complex, and proposed a long overdue name for the organism: Mycobacterium orygis. The authors described oryx bacillus as a separate taxon; the aim was for this description to be used in the future to identify the subspecies. Thus, we thought it pertinent to provide additional information that would be useful in speciating isolates of the oryx bacillus.
In a recent study, we genotyped an isolate of oryx bacillus obtained from an African buffalo in South Africa (2). This isolate was typed by using 16S rDNA, M. tuberculosis complexspecifi c multiplex-PCR, regions-ofdifference analyses, gyrase B gene single nucleotide polymorphism (SNP) analysis, spoligotyping, and mycobacterial interspersed repetitive units-variable number tandem repeat typing. We showed that, in addition to the markers described by van Ingen et al. (1) 
